Home / Latest Reports / E Pharma Market

e-Pharma Market By Mode - Global Industry Analysis And Forecast To 2027

Published On : December 2018 Pages : 180 Category: Pharmaceuticals Report Code : HC122175

Request Sample Inquiry Before Buying Request for Customization Check Discount

E-Pharma Market By Mode (Aggregator and Direct) - Global Industry Analysis And Forecast To 2027

Industry Outlook

e-Pharma is nothing but sell of pharmaceutical products through electronic media like internet. E-Pharma Market is rising across the globe due to the increased use of internet by world population. The factors behind growth of e-Pharma market are; rising knowledge amongst the people, advancement in healthcare services, availability of internet across the globe and increasing number of aged & ill people. Also the growth of ecommerce and digital methods is contributing to the growth of e-Pharma Market. Therefore, the e-Pharma Market is anticipated to expand and has tremendous scope during the forecast period. The global e-Pharma Market is anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

The global e-Pharma Market is based on segment, by Mode the market is segmented into Aggregator and Direct.

  • e-Pharma Market, By Mode
  • Aggregator
  • Direct

Regional Insights

On a global front, the e-Pharma Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, South Africa, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is leading the e-Pharma Market globally. Asia pacific region is seen growing after North American region, with India leading in this region.

e-Pharma Market, By Region

    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • South Africa
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The leading players in the market are Walmart Stores, Inc., Express Scripts Holding Company, AbbVie Contract Manufacturing, Boehringer Ingelheim, DocMorris, Aurobindo Pharma, Pfizer CentreSource, Optum Rx, Inc., Walgreen Co., Rowlands Pharmacy, CVS Health, Inc., The Kroger Co. and Giant Eagle. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

  • Walmart Stores, Inc.
  • Express Scripts Holding Company
  • AbbVie Contract Manufacturing
  • Boehringer Ingelheim
  • DocMorris
  • Aurobindo Pharma
  • Pfizer CentreSource
  • Optum Rx, Inc.
  • Walgreen Co.
  • Rowlands Pharmacy
  • CVS Health, Inc.
  • The Kroger Co.
  • Giant Eagle.  

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         e-Pharma Market, By Mode, Estimates and Forecast, 2017-2027 ($Million)

o    Aggregator

o    Direct

·         e-Pharma Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o    North America

§  North America e-Pharma Market, By Country

o    U.S. e-Pharma Market

o    Canada e-Pharma Market

o    Mexico e-Pharma Market

o    Europe

§  Europe e-Pharma Market, By Country

o    Germany e-Pharma Market

o    UK e-Pharma Market

o    France e-Pharma Market

o    Russia e-Pharma Market

o    Italy e-Pharma Market

o    Rest of Europe e-Pharma Market

o    Asia-Pacific

§  Asia-Pacific e-Pharma Market, By Country

o    China e-Pharma Market

o    Japan e-Pharma Market

o    South Korea e-Pharma Market

o    India e-Pharma Market

o    Southeast Asia e-Pharma Market

o    Rest of Asia-Pacific e-Pharma Market

o    South America

§  South America e-Pharma Market, By Country

o    Brazil e-Pharma Market

o    Argentina e-Pharma Market

o    Columbia e-Pharma Market

o    Rest of South America e-Pharma Market

o    Middle East and Africa

§  Middle East and Africa e-Pharma Market, By Country

o    Saudi Arabia e-Pharma Market

o    UAE e-Pharma Market

o    Egypt e-Pharma Market

o    Nigeria e-Pharma Market

o    South Africa e-Pharma Market

o    Rest of MEA e-Pharma Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2017-2027)

4.1.2.  Canada Market States and Outlook (2017-2027)

4.1.3.  Mexico Market States and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2017-2027)

4.2.2.  France Market States and Outlook (2017-2027)

4.2.3.  UK Market States and Outlook (2017-2027)

4.2.4.  Russia Market States and Outlook (2017-2027)

4.2.5.  Italy Market States and Outlook (2017-2027)

4.2.6.  Rest of Europe Market States and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2017-2027)

4.3.2.  Japan Market States and Outlook (2017-2027)

4.3.3.  Korea Market States and Outlook (2017-2027)

4.3.4.  India Market States and Outlook (2017-2027)

4.3.5.  Southeast Asia Market States and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market States and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2017-2027)

4.4.2.  Argentina Market States and Outlook (2017-2027)

4.4.3.  Columbia Market States and Outlook (2017-2027)

4.4.4.  Rest of South America Market States and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market States and Outlook (2017-2027)

4.5.3.  Egypt Market States and Outlook (2017-2027)

4.5.4.  Nigeria Market States and Outlook (2017-2027)

4.5.5.  South Africa Market States and Outlook (2017-2027)

4.5.6.  Turkey Market States and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market States and Outlook (2017-2027)

5.       E-Pharma  Market, By Mode

5.1.     Introduction

5.2.     Global E-Pharma  Revenue and Market Share by Mode (2017-2027)

5.2.1.  Global E-Pharma  Revenue and Revenue Share by Mode (2017-2027)

5.3.     Aggregator

5.3.1.  Global Aggregator Revenue and Growth Rate (2017-2027)

5.4.     Direct

5.4.1.  Global Direct Revenue and Growth Rate (2017-2027)

6.       E-Pharma  Market, By Region

6.1.     Introduction

6.2.     Global E-Pharma  Revenue and Market Share by Regions

6.2.1.  Global E-Pharma  Revenue by Regions (2017-2027)

6.3.     North America E-Pharma  by Countries

6.3.1.  North America E-Pharma  Revenue and Growth Rate (2017-2027)

6.3.2.  North America E-Pharma  Revenue (Million USD) by Countries (2017-2027)

6.3.3.  United States

6.3.3.1.  United States E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

6.3.4.  Canada

6.3.4.1.  Canada E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

6.3.5.  Mexico

6.3.5.1.  Mexico E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.     Europe E-Pharma  by Countries

6.4.1.  Europe E-Pharma  Revenue and Growth Rate (2017-2027)

6.4.2.  Europe E-Pharma  Revenue (Million USD) by Countries (2017-2027)

6.4.3.  Germany

6.4.3.1.  Germany E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.4.  France

6.4.4.1.  France E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.5.  UK

6.4.5.1.  UK E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.6.  Russia

6.4.6.1.  Russia E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.7.  Italy

6.4.7.1.  Italy E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.8.  Rest of Europe

6.4.8.1.  Rest of Europe E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.     Asia-Pacific E-Pharma  by Countries

6.5.1.  Asia-Pacific E-Pharma  Revenue and Growth Rate (2017-2027)

6.5.2.  Asia-Pacific E-Pharma  Revenue (Million USD) by Countries (2017-2027)

6.5.3.  China

6.5.3.1.  China E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.4.  Japan

6.5.4.1.  Japan E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.5.  Korea

6.5.5.1.  Korea E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.6.  India

6.5.6.1.  India E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.7.  Southeast Asia

6.5.7.1.  Southeast Asia E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.8.  Rest of Asia-Pacific

6.5.8.1.  Rest of Asia-Pacific E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.     South America E-Pharma  by Countries

6.6.1.  South America E-Pharma  Revenue and Growth Rate (2017-2027)

6.6.2.  South America E-Pharma  Revenue (Million USD) by Countries (2017-2027)

6.6.3.  Brazil

6.6.3.1.  Brazil E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.4.  Argentina

6.6.4.1.  Argentina E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.5.  Columbia

6.6.5.1.  Columbia E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.6.  Rest of South America

6.6.6.1.  Rest of South America E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.     Middle East and Africa E-Pharma  by Countries

6.7.1.  Middle East and Africa E-Pharma  Revenue and Growth Rate (2017-2027)

6.7.2.  Middle East and Africa E-Pharma  Revenue (Million USD) by Countries (2017-2027)

6.7.3.  Saudi Arabia

6.7.3.1.  Saudi Arabia E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.4.  United Arab Emirates

6.7.4.1.  United Arab Emirates E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.5.  Egypt

6.7.5.1.  Egypt E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.6.  Nigeria

6.7.6.1.  Nigeria E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.7.  South Africa

6.7.7.1.  South Africa E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.8.  Turkey

6.7.8.1.  Turkey E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.9.  Rest of Middle East and Africa

6.7.9.1.  Rest of Middle East and Africa E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

7.       Company Profiles

7.1.     Walmart Stores, Inc.

7.1.1.  Business Overview

7.1.2.   Service Portfolio

7.1.3.  Strategic Developments

7.1.4.   Revenue and Market Share

7.2.     Express Scripts Holding Company

7.2.1.  Business Overview

7.2.2.   Service Portfolio

7.2.3.  Strategic Developments

7.2.4.   Revenue and Market Share

7.3.     AbbVie Contract Manufacturing

7.3.1.  Business Overview

7.3.2.   Service Portfolio

7.3.3.  Strategic Developments

7.3.4.   Revenue and Market Share

7.4.     Boehringer Ingelheim

7.4.1.  Business Overview

7.4.2.   Service Portfolio

7.4.3.  Strategic Developments

7.4.4.   Revenue and Market Share

7.5.     DocMorris

7.5.1.  Business Overview

7.5.2.   Service Portfolio

7.5.3.  Strategic Developments

7.5.4.   Revenue and Market Share

7.6.     Aurobindo Pharma

7.6.1.  Business Overview

7.6.2.   Service Portfolio

7.6.3.  Strategic Developments

7.6.4.   Revenue and Market Share

7.7.     Pfizer CentreSource

7.7.1.  Business Overview

7.7.2.   Service Portfolio

7.7.3.  Strategic Developments

7.7.4.   Revenue and Market Share

7.8.     Optum Rx, Inc.

7.8.1.  Business Overview

7.8.2.   Service Portfolio

7.8.3.  Strategic Developments

7.8.4.   Revenue and Market Share

7.9.     Walgreen Co.

7.9.1.  Business Overview

7.9.2.   Service Portfolio

7.9.3.  Strategic Developments

7.9.4.   Revenue and Market Share

7.10. Rowlands Pharmacy

7.10.1.      Business Overview

7.10.2.       Service Portfolio

7.10.3.      Strategic Developments

7.10.4.       Revenue and Market Share

7.11. CVS Health, Inc.

7.11.1.      Business Overview

7.11.2.       Service Portfolio

7.11.3.      Strategic Developments

7.11.4.       Revenue and Market Share

7.12. The Kroger Co.

7.12.1.      Business Overview

7.12.2.       Service Portfolio

7.12.3.      Strategic Developments

7.12.4.       Revenue and Market Share

7.13. Giant Eagle. 

7.13.1.      Business Overview

7.13.2.       Service Portfolio

7.13.3.      Strategic Developments

7.13.4.       Revenue and Market Share

8.       Global E-Pharma  Market Competition, by Manufacturer

8.1.     Global E-Pharma  Revenue and Market Share by Manufacturer (2017-2017)

8.2.     Global E-Pharma  Price By Region (2017-2017)

8.3.     Top 5 E-Pharma  Manufacturer Market Share

8.4.     Market Competition Trend

9.       E-Pharma  Market Forecast (2017-2027)

9.1.     Global E-Pharma  Revenue (Millions USD) and Growth Rate (2017-2027)

9.2.     E-Pharma  Market Forecast by Regions (2017-2027)

9.2.1.  North America E-Pharma  Market Forecast (2017-2027)

9.2.1.1.  United States E-Pharma  Market Forecast (2017-2027)

9.2.1.2.  Canada E-Pharma  Market Forecast (2017-2027)

9.2.1.3.  Mexico E-Pharma  Market Forecast (2017-2027)

9.2.2.  Europe E-Pharma  Market Forecast (2017-2027)

9.2.2.1.  Germany E-Pharma  Market Forecast (2017-2027)

9.2.2.2.  France E-Pharma  Market Forecast (2017-2027)

9.2.2.3.  UK E-Pharma  Market Forecast (2017-2027)

9.2.2.4.  Russia E-Pharma  Market Forecast (2017-2027)

9.2.2.5.  Italy E-Pharma  Market Forecast (2017-2027)

9.2.2.6.  Rest of Europe E-Pharma  Market Forecast (2017-2027)

9.2.3.  Asia-Pacific E-Pharma  Market Forecast (2017-2027)

9.2.3.1.  China E-Pharma  Market Forecast (2017-2027)

9.2.3.2.  Japan E-Pharma  Market Forecast (2017-2027)

9.2.3.3.  Korea E-Pharma  Market Forecast (2017-2027)

9.2.3.4.  India E-Pharma  Market Forecast (2017-2027)

9.2.3.5.  Southeast Asia E-Pharma  Market Forecast (2017-2027)

9.2.3.6.  Rest of Asia-Pacific E-Pharma  Market Forecast (2017-2027)

9.2.4.  South America E-Pharma  Market Forecast (2017-2027)

9.2.4.1.  Brazil E-Pharma  Market Forecast (2017-2027)

9.2.4.2.  Argentina E-Pharma  Market Forecast (2017-2027)

9.2.4.3.  Columbia E-Pharma  Market Forecast (2017-2027)

9.2.4.4.  Rest of South America E-Pharma  Market Forecast (2017-2027)

9.2.5.  Middle East and Africa E-Pharma  Market Forecast (2017-2027)

9.2.5.1.  Saudi Arabia E-Pharma  Market Forecast (2017-2027)

9.2.5.2.  United Arab Emirates E-Pharma  Market Forecast (2017-2027)

9.2.5.3.  Egypt E-Pharma  Market Forecast (2017-2027)

9.2.5.4.  Nigeria E-Pharma  Market Forecast (2017-2027)

9.2.5.5.  South Africa E-Pharma  Market Forecast (2017-2027)

9.2.5.6.  Turkey E-Pharma  Market Forecast (2017-2027)

9.2.5.7.  Rest of Middle East and Africa E-Pharma  Market Forecast (2017-2027)

9.3.     E-Pharma  Market Forecast by Mode (2017-2027)

9.3.1.  E-Pharma  Forecast by Mode (2017-2027)

9.3.2.  E-Pharma  Market Share Forecast by Mode (2017-2027)

List of Tables

List of Tables and Figures:

Figure United States E-Pharma Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada E-Pharma Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico E-Pharma Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany E-Pharma Revenue (Million USD) and Growth Rate (2017-2025)
Figure France E-Pharma Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK E-Pharma Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia E-Pharma Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy E-Pharma Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe E-Pharma Revenue (Million USD) and Growth Rate (2017-2025)
Figure China E-Pharma Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan E-Pharma Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea E-Pharma Revenue (Million USD) and Growth Rate (2017-2025)
Figure India E-Pharma Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia E-Pharma Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific E-Pharma Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil E-Pharma Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina E-Pharma Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia E-Pharma Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America E-Pharma Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia E-Pharma Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates E-Pharma Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt E-Pharma Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria E-Pharma Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa E-Pharma Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey E-Pharma Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa E-Pharma Revenue (Million USD) and Growth Rate (2017-2025)
Table Global E-Pharma Revenue and Revenue Share by Mode (2017-2018)
Figure Global Aggregator Revenue and Growth Rate (2017-2018)
Figure Global Direct Revenue and Growth Rate (2017-2018)
Table Global E-Pharma Revenue by Regions (2017-2018)
Figure North America E-Pharma Growth Rate (2017-2018)
Figure North America E-Pharma Revenue and Growth Rate (2017-2018)
Figure North America E-Pharma by Countries (2017-2018)
Figure North America E-Pharma Revenue (Million USD) by Countries (2017-2018)
Figure United States E-Pharma Growth Rate (2017-2018)
Figure United States E-Pharma Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada E-Pharma Growth Rate (2017-2018)
Figure Canada E-Pharma Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico E-Pharma Growth Rate (2017-2018)
Figure Mexico E-Pharma Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe E-Pharma Growth Rate (2017-2018)
Figure Europe E-Pharma Revenue and Growth Rate (2017-2018)
Figure Europe E-Pharma by Countries (2017-2018)
Figure Europe E-Pharma Revenue (Million USD) by Countries (2017-2018)
Figure Germany E-Pharma Growth Rate (2017-2018)
Figure Germany E-Pharma Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France E-Pharma Growth Rate (2017-2018)
Figure France E-Pharma Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK E-Pharma Growth Rate (2017-2018)
Figure UK E-Pharma Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia E-Pharma Growth Rate (2017-2018)
Figure Russia E-Pharma Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy E-Pharma Growth Rate (2017-2018)
Figure Italy E-Pharma Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe E-Pharma Growth Rate (2017-2018)
Figure Rest of Europe E-Pharma Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific E-Pharma Growth Rate (2017-2018)
Figure Asia-Pacific E-Pharma Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific E-Pharma by Countries (2017-2018)
Figure Asia-Pacific E-Pharma Revenue (Million USD) by Countries (2017-2018)
Figure China E-Pharma Growth Rate (2017-2018)
Figure China E-Pharma Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan E-Pharma Growth Rate (2017-2018)
Figure Japan E-Pharma Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea E-Pharma Growth Rate (2017-2018)
Figure Korea E-Pharma Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India E-Pharma Growth Rate (2017-2018)
Figure India E-Pharma Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia E-Pharma Growth Rate (2017-2018)
Figure Southeast Asia E-Pharma Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific E-Pharma Growth Rate (2017-2018)
Figure Rest of Asia-Pacific E-Pharma Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America E-Pharma Growth Rate (2017-2018)
Figure South America E-Pharma Revenue and Growth Rate (2017-2018)
Figure South America E-Pharma by Countries (2017-2018)
Figure South America E-Pharma Revenue (Million USD) by Countries (2017-2018)
Figure Brazil E-Pharma Growth Rate (2017-2018)
Figure Brazil E-Pharma Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina E-Pharma Growth Rate (2017-2018)
Figure Argentina E-Pharma Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia E-Pharma Growth Rate (2017-2018)
Figure Columbia E-Pharma Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America E-Pharma Growth Rate (2017-2018)
Figure Rest of South America E-Pharma Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa E-Pharma Growth Rate (2017-2018)
Figure Middle East and Africa E-Pharma Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa E-Pharma by Countries (2017-2018)
Figure Middle East and Africa E-Pharma Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia E-Pharma Growth Rate (2017-2018)
Figure Saudi Arabia E-Pharma Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates E-Pharma Growth Rate (2017-2018)
Figure United Arab Emirates E-Pharma Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt E-Pharma Growth Rate (2017-2018)
Figure Egypt E-Pharma Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria E-Pharma Growth Rate (2017-2018)
Figure Nigeria E-Pharma Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa E-Pharma Growth Rate (2017-2018)
Figure South Africa E-Pharma Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey E-Pharma Growth Rate (2017-2018)
Figure Turkey E-Pharma Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa E-Pharma Growth Rate (2017-2018)
Figure Rest of Middle East and Africa E-Pharma Revenue (Millions USD) and Growth Rate (2017-2018)
Table Walmart Stores, Inc. E-Pharma Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Express Scripts Holding Company E-Pharma Price, Revenue, Gross Margin and Market Share (2017-2017)
Table AbbVie Contract Manufacturing E-Pharma Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Boehringer Ingelheim E-Pharma Price, Revenue, Gross Margin and Market Share (2017-2017)
Table DocMorris E-Pharma Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Aurobindo Pharma E-Pharma Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pfizer CentreSource E-Pharma Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Optum Rx, Inc. E-Pharma Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Walgreen Co. E-Pharma Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Rowlands Pharmacy E-Pharma Price, Revenue, Gross Margin and Market Share (2017-2017)
Table CVS Health, Inc. E-Pharma Price, Revenue, Gross Margin and Market Share (2017-2017)
Table The Kroger Co. E-Pharma Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Giant Eagle. E-Pharma Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global E-Pharma Market Share by Manufacturer
Figure Global E-Pharma Revenue and Market Share by Manufacturer
Table Global E-Pharma Price by Region (2017-2017)
Figure Top 5 E-Pharma Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global E-Pharma Revenue (Millions USD) and Growth Rate (2018-2025)
Table E-Pharma Market Forecast by Regions (2018-2025)
Figure North America E-Pharma Market Forecast (2018-2025)
Figure United States E-Pharma Market Forecast (2018-2025)
Figure Canada E-Pharma Market Forecast (2018-2025)
Figure Mexico E-Pharma Market Forecast (2018-2025)
Figure Europe E-Pharma Market Forecast (2018-2025)
Figure Germany E-Pharma Market Forecast (2018-2025)
Figure France E-Pharma Market Forecast (2018-2025)
Figure UK E-Pharma Market Forecast (2018-2025)
Figure Russia E-Pharma Market Forecast (2018-2025)
Figure Italy E-Pharma Market Forecast (2018-2025)
Figure Rest of Europe E-Pharma Market Forecast (2018-2025)
Figure Asia-Pacific E-Pharma Market Forecast (2018-2025)
Figure China E-Pharma Market Forecast (2018-2025)
Figure Japan E-Pharma Market Forecast (2018-2025)
Figure Korea E-Pharma Market Forecast (2018-2025)
Figure India E-Pharma Market Forecast (2018-2025)
Figure Southeast Asia E-Pharma Market Forecast (2018-2025)
Figure Rest of Asia-Pacific E-Pharma Market Forecast (2018-2025)
Figure South America E-Pharma Market Forecast (2018-2025)
Figure Brazil E-Pharma Market Forecast (2018-2025)
Figure Argentina E-Pharma Market Forecast (2018-2025)
Figure Columbia E-Pharma Market Forecast (2018-2025)
Figure Rest of South America E-Pharma Market Forecast (2018-2025)
Figure Middle East and Africa E-Pharma Market Forecast (2018-2025)
Figure Saudi Arabia E-Pharma Market Forecast (2018-2025)
Figure United Arab Emirates E-Pharma Market Forecast (2018-2025)
Figure Egypt E-Pharma Market Forecast (2018-2025)
Figure Nigeria E-Pharma Market Forecast (2018-2025)
Figure South Africa E-Pharma Market Forecast (2018-2025)
Figure Turkey E-Pharma Market Forecast (2018-2025)
Figure Rest of Middle East and Africa E-Pharma Market Forecast (2018-2025)
Figure Global E-Pharma Forecast by Mode (2018-2025)
Figure Global E-Pharma Market Share Forecast by Mode (2018-2025)
Figure Global E-Pharma Forecast by Mode (2018-2025)

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*